Quintiles
Helps pharmaceutical, biotechnology and medical device companies develop and market innovative therapies.
Financials
Estimates*
| GBP | 2015 | 2016 |
|---|---|---|
| Revenues | 7.3m | 17.9m |
| % growth | - | 147 % |
| EBITDA | <1m | 2.2m |
| % EBITDA margin | 3 % | 12 % |
| Profit | <1m | 2.1m |
| % profit margin | 4 % | 12 % |
| R&D budget | 57.5m | - |
| R&D % of revenue | 792 % | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Late VC | ||
$525m | Debt | ||
| N/A | $1.0m | Grant | |
$9.0b | Merger | ||
| Total Funding | AUD1.5m | ||
Related Content
Recent News about Quintiles
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Quintiles
Edit
ACQUISITION by Quintiles Oct 2011
ACQUISITION by Quintiles Oct 2011
ACQUISITION by Quintiles Sep 2013
ACQUISITION by Quintiles May 2008
ACQUISITION by Deerfield Capital Management Jan 2009